| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −15.3× | −1.7× | |
| Price / Book | 4.7× | 2.0× | |
| Price / Sales | 0.6× | 4.0× | |
| Price / Free cash flow | −87.6× | −1.5× | |
| EV / EBITDA | −51.4× | −1.2× | |
| Earnings yield | −6.6% | −14.4% | |
| Free cash flow yield | −1.1% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,295.22 | +4.42% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $258.60 | +1.90% | $623.2B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.02 | +1.89% | $508.97B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $414.86 | +1.96% | $372.38B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $147.85 | +2.94% | $364.77B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.36 | +1.44% | $280.87B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $167.62 | +2.24% | $259.96B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $684.78 | +0.79% | $253.2B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $434.22 | +2.18% | $234.75B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.61 | +1.66% | $192.95B | 22.3× | 37.5% | +29.9% |
